Skip to main navigation Skip to search Skip to main content

Emerging Targets in Type 2 Diabetes and Diabetic Complications

  • Sevgican Demir
  • , Peter P. Nawroth
  • , Stephan Herzig
  • , Bilgen Ekim Üstünel
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • Universitätsklinikum Heidelberg
  • German Centre for Diabetes Research (DZD)

Research output: Contribution to journalReview articlepeer-review

481 Scopus citations

Abstract

Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.

Original languageEnglish
Article number2100275
JournalAdvanced Science
Volume8
Issue number18
DOIs
StatePublished - 22 Sep 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • insulin resistance
  • metabolism
  • signaling pathways
  • type 2 diabetes, diabetic complications

Fingerprint

Dive into the research topics of 'Emerging Targets in Type 2 Diabetes and Diabetic Complications'. Together they form a unique fingerprint.

Cite this